The Drug Safety and Information Department processes drug information (medical) and pharmacovigilance (drug safety) enquiries, including suspected adverse drug reactions (side effects). Drug Safety and Information departments are prohibited from commenting on or providing advice on a patient’s medication or treatment. Patients and their representatives must discuss all matters of this nature with the patient’s doctor.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.
By reporting side effects, you can help to provide more information on the safety of medicines.
Suspected side effects should also be reported to the marketing authorisation holder. Their name can be found on the product pack or in the package leaflet. If you have a suspected side effect related to medication for which Wockhardt UK Limited is the marketing authorisation holder, please complete our contact form and select the ‘report a suspected side effect’ option from the ‘nature of enquiry’ menu, stating the PL Number for the product concerned in the ‘message’ box.
All the information and personal data you share with the company in your email enquiry will be protected and kept confidential in line with Wockhardt UK Limited’s company policy and local regulation. The information you provide will be used for the purpose of drug safety surveillance and will enable the company to deal with your enquiry appropriately. If applicable, the information you provide may also be forwarded to the medicines regulatory authorities in the United Kingdom and/or European Union. You have the right to access any personal data the company holds in relation to you.
This website has been produced by Wockhardt UK Ltd and is intended for UK based health professionals only
Contact Us | Cookies and Privacy Policy | Terms of and Conditions of Use | PIL | Pharmacovigilance Privacy Notice
Job code: CSB02/23 March 2023
